"WILL" not started yet, too much stupidity going on, I thought, HERP V should work with our newly biologic components
I don't think that was his real time voice this time. They just replayed an audio from the previous 20 or so CC's. He has an emergency on the farm and couldn't make it.
From the conf call: We will also continue to pursue additional strategic alliances and partnerships that will help us build a leadership position in immuno-oncology as well as in immunology, which includes other diseases and conditions which are mediated by the immune system.
This how a competent CEO Dr. David T. Hung M.D.rewards his shareholders vs CEPGaro Armen F.A.M....
MDVN was just bought out for 9 million dollars by Sanofi. Their stock was trading aprox at the same price as the sleepy Turk stock AGEN back in June 2006. They had two 2 for 1 stock splits since ( not a 6 for 1 reverse) like sleepy did to stay alive on NASD in Oct 2011 with a name change. They have 940 million in sales (we have zilch) and MDVN shareholders can cash in big time with the proposed merger now. Sleepy is the wrong guy after 16 years of BS he must get replaced by some one that knows the business how to increase shareholders value. All pie in the sky with this guy. The current price of $3.58 must be divided by 6 which equals .60 cents a share. While the shareholders in MDVN got the equivalent of 4X the amount of stock they owned after the two 50% stock splitsin back 2006 and the price is now $59 a share. Thats a real CEO not a New England organic farmer. Less Less
I'm just confused because we seemed like we were talking about two different things. Prophage update on pivotal trial is supposed to be Q3 (or as you say, Q4 - LOL). This thread was about the start of PI in solid tumors. Couldn't understand what July had to do with this thread...?
Agree, but Stein must found something and believe that he can prove something, my guess, he is trying to validate quickly toxicity / safety of it, and we can start PII on bettr candidate to prove efficacy.
good point. Then AGEN should take what we have learned and apply it to something else. Not to waste time and money. Like there doing with HerpV. Combo's sounds good?
Yeah...but, the question remains...why do we need a P3 for brain cancer ??
These people are the worst of the worst. They're going to die. You won't hurt them any more by giving them an autologous vaccine. There are no adverse reactions.
Why not allow us to market it with mandated follow-up studies ??
A P3 will take years and will only help a handful of patients.
If there ever was a need for "compassionate use" or accelerated approval" or whatever, shouldn't it be for brain cancer ??